S-Bank Fund Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
S-Bank Fund Management's REGN Position: Q2 2026 in Review
S-Bank Fund Management increased its Regeneron Pharmaceuticals (REGN) stake by 70% in Q2 2026, buying an estimated $285K and bringing the position to 1,012 shares worth $631K. The position accounts for 0.09% of the portfolio, ranked #127.
S-Bank Fund Management first reported a position in REGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $658K in Q1 2025. 1,339 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- S-Bank Fund Management held 1,012 shares of Regeneron Pharmaceuticals worth $631K as of Q2 2026.
- S-Bank Fund Management bought 418 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $285K.
- Regeneron Pharmaceuticals made up 0.09% of S-Bank Fund Management's portfolio in Q2 2026, its #127 holding.
- S-Bank Fund Management first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
- S-Bank Fund Management's Regeneron Pharmaceuticals position peaked at $658K in Q1 2025.
- 1,339 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on S-Bank Fund Management's 13F filing for Q2 2026, filed 4 Aug 2026.